William K. Heiden
2015
In 2015, William K. Heiden earned a total compensation of $3.7M as Chief Executive Officer at AMAG Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $399,600 |
|---|---|
| Option Awards | $1,257,954 |
| Salary | $583,719 |
| Stock Awards | $1,483,800 |
| Other | $7,950 |
| Total | $3,733,023 |
Heiden received $1.5M in stock awards, accounting for 40% of the total pay in 2015.
Heiden also received $399.6K in non-equity incentive plan, $1.3M in option awards, $583.7K in salary and $8K in other compensation.
Rankings
In 2015, William K. Heiden's compensation ranked 2,389th out of 13,638 executives tracked by ExecPay. In other words, Heiden earned more than 82.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,389 out of 13,638 | 83rd |
Division Manufacturing | 856 out of 5,190 | 84th |
Major group Chemicals And Allied Products | 310 out of 1,854 | 83rd |
Industry group Drugs | 246 out of 1,528 | 84th |
Industry Pharmaceutical Preparations | 193 out of 1,182 | 84th |
Source: SEC filing on April 20, 2017.
Heiden's colleagues
We found six more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2015.
2015
Geoffrey Crouse
AMAG Pharmaceuticals
Chief Executive Officer
2015
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2015
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2015
Joseph Vittiglio
AMAG Pharmaceuticals
General Counsel
2015
Kenneth Wilson
AMAG Pharmaceuticals
Former Senior Vice President, Sales and Marketing, and President of Lumara Health Division
2015
Scott Holmes
AMAG Pharmaceuticals